CAPTRUST FINANCIAL ADVISORS - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 52 filers reported holding SIO GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q2 2022$0
-100.0%
1,0180.0%0.00%
Q1 2022$1,0000.0%1,0180.0%0.00%
Q4 2021$1,000
-50.0%
1,0180.0%0.00%
Q3 2021$2,000
-33.3%
1,0180.0%0.00%
Q2 2021$3,0001,018
+5555.6%
0.00%
Q1 2021$0180.0%0.00%
Q4 2020$0180.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 310,500$863,0001.79%
Consonance Capital Management LP 3,186,335$8,858,0000.83%
Opaleye Management Inc. 2,000,000$5,560,0000.73%
Sio Capital Management, LLC 886,665$2,465,0000.50%
Rubric Capital Management LP 2,335,200$6,492,0000.48%
Affinity Asset Advisors, LLC 250,000$695,0000.37%
GSA CAPITAL PARTNERS LLP 354,265$985,0000.16%
Hudson Bay Capital Management LP 3,200,000$8,896,0000.05%
Insight Advisors, LLC/ PA 24,000$67,0000.02%
Maven Securities LTD 86,788$246,0000.02%
View complete list of SIO GENE THERAPIES INC shareholders